Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


J&J/Merck submits data supporting Pepcid AC 30-minutes-before-eating claim.

This article was originally published in The Tan Sheet

Executive Summary

PEPCID AC 30-MINUTES-BEFORE-EATING PREVENTION CLAIM IS PENDING AT FDA, Merck Senior VP-Clinical and Regulatory Affairs Eve Slater, MD, told securities analysts at a May 21 meeting in Rahway, N.J. Merck reported that it filed for the new heartburn prevention dosing regimen on March 29.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts